Cidara Therapeutics, Inc. ( CDTX) - Stock Earnings
Stock symbol CDTX is outdated, potentially delisted? Maybe it is available on other exchange?
CDTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -10.3 million USD | 8.5 million USD |
| 2024Q2 | -89.4 million USD | 302000 USD |
| 2024Q3 | -15.5 million USD | — USD |
CDTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -43.9 million USD | 49.6 million USD |
| 2022 | -29.8 million USD | 64.3 million USD |
| 2023 | -22.9 million USD | 63.9 million USD |
CDTX
Price: $221.38
52 week price:
Earnings Per Share: -11.21 USD
P/E Ratio: -19.72
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.0 million
Ebitda: -12.1 millionMarket Capitalization: 5.6 billion